KEGG icon

Drug interaction list


Query:
D05792  Salmeterol (USAN/INN)

Interactions: 125 hits    [ ATC classification | Therapeutic category ]

D00095  Epinephrine (USP/INN); Adrenaline (JP18); Adrenalin (TN); Auvi-q (TN); Epipen (TN) (CI) Target: ADRB2
D00211  Rifampin (USP); Rifampicin (JP18/INN); Rifadin (TN); Rimactane (TN) (P) CYP induction: CYP3A4
D00228  Amoxapine (JP18/USP/INN); Asendin (TN) (P) unclassified
D00235  Atenolol (JP18/USP/INN); Tenormin (TN) (P) unclassified
D00255  Carvedilol (JP18/USP/INN); Artist (TN); Coreg (TN) (P) Enzyme: CYP3A4 / Target: ADRB2
D00283  Clozapine (JAN/USP/INN); Clozaril (TN) (CI) Enzyme: CYP3A4
D00292  Dexamethasone (JP18/USP/INN); Decadron (TN); Maxidex (TN) (P) Enzyme: CYP3A4 / CYP induction: CYP3A4
D00293  Diazepam (JP18/USP/INN); Diastat (TN); Valium (TN) (P) Enzyme: CYP3A4
D00298  Digoxin (JP18/USP); Lanoxicaps (TN); Lanoxin (TN) (P) unclassified
D00346  Isoniazid (JP18/USP/INN); Laniazid (TN) (P) unclassified
D00350  Itraconazole (JP18/USP); Itrizole (TN); Sporanox (TN) (P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4
D00371  Theophylline (JP18); Elixophyllin (TN); Quibron-t (TN); Theo-24 (TN); Theodur G (TN); Theolair (TN); Uniphyl (TN) (P) unclassified
D00420  Mitotane (JAN/USP/INN); Lysodren (TN) (P) unclassified
D00435  Nevirapine (JAN/USP/INN); Viramune (TN) (P) Enzyme: CYP3A4
D00478  Procarbazine hydrochloride (JP18/USP); Matulane (TN) (P) unclassified
D00483  Propranolol hydrochloride (JP18/USP); Inderal (TN); Innopran XL (TN) (P) Target: ADRB2
D00506  Phenobarbital (JP18/USP/INN); Luminal (TN) (P) unclassified
D00512  Phenytoin (JP18/USP/INN); Dilantin (TN) (P) unclassified
D00513  Pindolol (JP18/USP/INN); Blocklin-L (TN); Carvisken (TN); Visken (TN) (P) Target: ADRB2
D00528  Caffeine (USP); Anhydrous caffeine (JP18); Anhydrous caffeine (TN); Respia (TN) (P) unclassified
D00550  Midazolam (JAN/USP/INN); Dormicum (TN); Buccolam (TN); Nayzilam (TN) (P) Enzyme: CYP3A4
D00600  Labetalol hydrochloride (JP18/USP); Normodyne (TN); Trandate (TN) (P) Target: ADRB2
D00636  Amiodarone hydrochloride (JP18/USP); Ancaron (TN); Cordarone (TN); Nexterone (TN) (P) Enzyme: CYP3A4
D00644  Esmolol hydrochloride (JAN/USP); Brevibloc (TN) (P) unclassified
D00701  Phenobarbital sodium (JAN/USP/INN); Luminal sodium (TN) (P) unclassified
D00780  Bromocriptine mesylate (USP); Bromocriptine mesilate (JP18); Parlodel (TN) (P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4
D00785  Selegiline hydrochloride (JAN/USP); Eldepryl (TN) (P) Enzyme: CYP3A4
D00809  Amitriptyline hydrochloride (JP18/USP); Elavil (TN) (P) Enzyme: CYP3A4
D00811  Clomipramine hydrochloride (JP18/USP); Anafranil (TN) (P) Enzyme: CYP3A4
D00815  Imipramine hydrochloride (JP18/USP); Tofranil (TN) (P) Enzyme: CYP3A4
D00816  Nortriptyline hydrochloride (JP18/USP/INN); Pamelor (TN) (P) unclassified
D00818  Maprotiline hydrochloride (JP18/USP); Ludiomil (TN) (P) unclassified
D00831  Mefloquine hydrochloride (JP18/USP); Lariam (TN) (P) unclassified
D00947  Linezolid (JAN/USAN/INN); Zyvox (TN) (P) unclassified
D00961  Bicalutamide (JP18/USP/INN); Casodex (TN) (P) CYP inhibition: CYP3A4
D00973  Cortisone acetate (JP18/USP); Cortone acetate (TN) (P) unclassified
D00977  Hydrocortisone sodium phosphate (JP18/USP); Hydrocortone phosphate (TN) (P) unclassified
D00999  Acetylcholine chloride (JP18/USP/INN); Miochol (TN) (P) unclassified
D01010  Levothyroxine sodium (USP); Levothyroxine sodium hydrate (JP18); Levothroid (TN); Levoxyl (TN); Synthroid (TN) (P) unclassified
D01011  Liothyronine sodium (JP18/USP); Cytomel (TN); Triostat (TN) (P) unclassified
D01026  Sotalol hydrochloride (JAN/USP); Betapace (TN); Sorine (TN) (P) Target: ADRB2
D01240  Deslanoside (JP18/USP/INN); Cedilanid-d (TN) (P) unclassified
D01253  Clobazam (JAN/USAN/INN); Mystan (TN); Onfi (TN) (P) Enzyme: CYP3A4
D01263  Ritodrine hydrochloride (JP18/USP); Yutopar (TN) (P) Target: ADRB2
D01276  Atazanavir sulfate (JAN/USAN); Reyataz (TN) (P) CYP inhibition: CYP3A4
D01285  Lofepramine hydrochloride (JAN/USAN); Amplit (TN) (P) unclassified
D01390  Isoproterenol hydrochloride (USP); dl-Isoprenaline hydrochloride (JAN); Isuprel (TN); Proternol-S (TN) (P) Target: ADRB2
D01546  Dothiepin hydrochloride (USAN); Dosulepin hydrochloride (JAN); Dosulepin (TN) (P) unclassified
D01748  Isoxsuprine hydrochloride (JP18/USP); Duvadilan (TN) (P) Target: ADRB2
D01847  Landiolol hydrochloride (JAN/USAN); ONO 1101 hydrochloride; Onoact (TN) (P) unclassified
D01856  Nifekalant hydrochloride (JAN); MS 551; Shinbit (TN) (P) unclassified
D01872  Doxapram hydrochloride (USP); Doxapram hydrochloride hydrate (JP18); Dopram (TN) (P) Enzyme: CYP3A4
D02002  Isoniazid sodium methanesulfonate hydrate (JAN); Isoniazid sodium methanesulfonate monohydrate; Isoniazid sodium methanesulfonate; IHMS; Neoiscotin (TN) (P) unclassified
D02103  Phenytoin sodium (USP); Phenytoin sodium for injection (JP18); Aleviatin (TN); Dilantin (TN) (P) unclassified
D02150  l-Isoprenaline hydrochloride (JP18); Proternol-L (TN) (P) Target: ADRB2
D02372  Perospirone hydrochloride hydrate (JAN); Lullan (TN) (P) unclassified
D02484  Artemether and lumefantrine; Coartem (TN) (P) unclassified
D02562  Rasagiline mesylate (USAN); Rasagiline mesilate (JAN); Azilect (TN) (P) unclassified
D02574  Atomoxetine hydrochloride (JAN/USP); Tomoxetine hydrochloride; Strattera (TN) (P) unclassified
D02587  Metildigoxin (JP18); Lanirapid (TN) (P) unclassified
D02691  Somatropin (USP/INN); Somatropin (genetical recombination) (JAN); Human growth hormone (JAN); Asellacrin (TN); Humatrope (TN); Nutropin (TN); Omnitrope (TN) (P) unclassified
D02732  Pranlukast hydrate (JP18); Onon (TN) (P) Enzyme: CYP3A4
D02867  Fosamprenavir calcium hydrate (JAN); Lexiva (TN) (CI) Enzyme: CYP3A4 / CYP inhibition: CYP3A4
D02968  Aprepitant (JAN/USP/INN); Aponvie (TN); Emend (TN); Cinvanti (TN) (P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4
D03106  Bexarotene (JAN/USAN/INN); Targretin (TN) (P) unclassified
D03365  Nicotine (USP); Habitrol (TN) (P) unclassified
D03658  Dasatinib (JAN/INN) (P) Enzyme: CYP3A4
D03669  Deferasirox (JAN/USAN/INN); Exjade (TN); Jadenu (TN) (P) CYP induction: CYP3A4
D04024  Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN); Lapatinib ditosylate monohydrate; Tykerb (TN); Tyverb (TN) (P) Enzyme: CYP3A4
D04052  Epinephrine and lidocaine hydrochloride; Adrenaline and lidocaine hydrochloride; Xylocaine (TN) (CI) Enzyme: CYP3A4
D04059  Mepenzolate bromide and phenobarbital; Trancolon P (TN) (P) unclassified
D04641  Istradefylline (JAN/USAN/INN); Nourianz (TN); Nouriast (TN) (P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4
D04666  Lanreotide acetate (JAN/USAN); Somatuline (TN) (P) unclassified
D04970  Methacholine chloride (JAN/USP/INN); Provocholine (TN) (P) unclassified
D05037  Trimetoquinol hydrochloride hydrate (JP18); Tretoquinol hydrate; Caluyon (TN) (P) Target: ADRB2
D05429  Aminophylline hydrate (JP18) (P) unclassified
D05775  Rufinamide (JAN/USP/INN); Banzel (TN) (P) unclassified
D06413  Nilotinib hydrochloride hydrate (JAN); Nilotinib monohydrochloride monohydrate; Tasigna (TN) (P) Enzyme: CYP3A4
D06414  Dasatinib (USAN); Dasatinib hydrate (JAN); Sprycel (TN) (P) Enzyme: CYP3A4
D06478  Darunavir ethanolate (JAN); Prezista (TN) (P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4
D06597  Fosaprepitant dimeglumine (USAN); Fosaprepitant meglumine (JAN); Proemend (TN) (P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4
D07583  Phenytoin and phenobarbital; Aleviatin with phenobarbital (TN) (P) unclassified
D07595  Fosphenytoin sodium hydrate (JAN); Fostoin (TN) (P) CYP induction: CYP3A4
D09319  Indacaterol maleate (JAN/USAN); Arcapta neohaler (TN) (P) Enzyme: CYP3A4 / Target: ADRB2
D09638  Lomitapide mesylate (USAN); Lomitapide mesilate (JAN); Juxtapid (TN); Lojuxta (TN) (P) Enzyme: CYP3A4
D09731  Crizotinib (JAN/USAN/INN); Xalkori (TN) (P) Enzyme: CYP3A4
D09799  Carotegrast methyl (JAN); Carogra (TN) (P) CYP inhibition: CYP3A4
D09996  Vemurafenib (JAN/USAN/INN); Zelboraf (TN) (P) CYP induction: CYP3A4
D10003  Hemin (JAN); Normosang (TN); Panhematin (TN) (P) CYP induction: CYP3A4
D10104  Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN); Tafinlar (TN) (P) Enzyme: CYP3A4 / CYP induction: CYP3A4
D10161  Sarilumab (USAN); Sarilumab (genetical receombination) (JAN); Kevzara (TN) (P) unclassified
D10191  Safinamide mesylate (USAN); Safinamide mesilate (JAN); Safinamide methanesulfonate; Xadago (TN); Equfina (TN) (P) unclassified
D10218  Enzalutamide (JAN/USAN); Xtandi (TN) (P) unclassified
D10252  Fexofenadine hydrochloride and pseudoephedrine hydrochloride; Allegra-d (TN) (P) unclassified
D10372  Palbociclib (JAN/USAN); Ibrance (TN) (P) unclassified
D10466  Vonoprazan fumarate (JAN/USAN); Takecab (TN); Voquezna (TN) (P) Enzyme: CYP3A4
D10505  Glycopyrronium bromide and indacaterol maleate; Ultibro (TN) (P) Enzyme: CYP3A4
D10551  Ceritinib (JAN/USAN/INN); Zykadia (TN) (P) unclassified
D10564  Amenamevir (JAN/INN); Amenalief (TN) (P) unclassified
D10566  Pasireotide pamoate (JAN); Signifor lar (TN) (P) unclassified
D10643  Isavuconazonium sulfate (JAN/USAN); Cresemba (TN) (P) unclassified
D10744  Tiotropium and olodaterol; Spiolto (TN); Stiolto respimat (TN) (P) unclassified
D10762  Fosravuconazole L-lysine ethanolate (JAN) (P) unclassified
D10774  Vonoprazan, amoxicillin and metronidazole; Vonopion (TN) (P) Enzyme: CYP3A4
D10775  Vonoprazan, amoxicillin and clarithromycin; Vonosap (TN); Voquenza (TN) (P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4
D10801  Letermovir (JAN/USAN/INN); Prevymis (TN) (P) unclassified
D10832  Darunavir and cobicistat; Prezcobix (TN); Rezolsta (TN) (P) unclassified
D10926  Entrectinib (JAN/USAN/INN); Rozlytrek (TN) (P) Enzyme: CYP3A4
D10990  Somatrogon (USAN/INN); Somatrogon (genetical recombination) (JAN); Somatrogon-ghla; Ngenla (TN) (P) unclassified
D11012  Lorlatinib (JAN/USAN/INN); Lorbrena (TN) (P) unclassified
D11040  Apalutamide (JAN/INN); Erleada (TN) (P) Enzyme: CYP3A4 / CYP induction: CYP3A4
D11138  Larotrectinib sulfate (JAN/USAN); Vitrakvi (TN) (P) unclassified
D11194  Somapacitan (USAN/INN); Somapacitan (genetical recombination) (JAN); Somapacitan-beco; Sogroya (TN) (P) unclassified
D11370  Fosnetupitant chloride hydrochloride (JAN/USAN); Arokaris (TN) (P) unclassified
D11382  Darunavir, cobicistat, emtricitabine and tenofovir alafenamide; Symtuza (TN) (P) unclassified
D11485  Tazemetostat hydrobromide (JAN/USAN); Tazverik (TN) (P) unclassified
D11674  Berotralstat hydrochloride (JAN/USAN); Orladeyo (TN) (P) CYP inhibition: CYP3A4
D11713  Selpercatinib (JAN/USAN/INN); Retevmo (TN) (P) Enzyme: CYP3A4
D11804  Aspirin and vonoprazan; Cabpirin (TN) (P) unclassified
D11861  Indacaterol acetate, glycopyrronium bromide and mometasone furoate; Enerzair (TN) (P) unclassified
D11862  Indacaterol and mometasone furoate; Atectura (TN) (P) unclassified
D11920  Pimitespib (JAN); Jeselhy (TN) (P) unclassified
D11970  Ritlecitinib tosylate (USAN); Ritlecitinib tosilate (JAN); Litfulo (TN) (P) unclassified
D12055  Sotorasib (JAN/USAN); Lumakras (TN) (P) unclassified
D12586  Mifepristone and misoprostol; Mefeego (TN) (P) unclassified